A detailed history of Pro Share Advisors LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 38,129 shares of SANA stock, worth $105,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,129
Previous 26,526 43.74%
Holding current value
$105,998
Previous $144,000 9.72%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.76 - $6.86 $43,627 - $79,596
11,603 Added 43.74%
38,129 $158,000
Q2 2024

Aug 13, 2024

SELL
$5.23 - $10.44 $32,237 - $64,352
-6,164 Reduced 18.86%
26,526 $144,000
Q1 2024

May 08, 2024

BUY
$4.2 - $11.27 $17,682 - $47,446
4,210 Added 14.78%
32,690 $326,000
Q4 2023

Feb 14, 2024

BUY
$2.8 - $4.55 $9,772 - $15,879
3,490 Added 13.97%
28,480 $116,000
Q3 2023

Nov 13, 2023

BUY
$3.77 - $6.23 $1,775 - $2,934
471 Added 1.92%
24,990 $96,000
Q2 2023

Aug 10, 2023

BUY
$3.22 - $7.53 $2,640 - $6,174
820 Added 3.46%
24,519 $146,000
Q1 2023

May 11, 2023

SELL
$3.11 - $4.92 $10,925 - $17,283
-3,513 Reduced 12.91%
23,699 $77,000
Q4 2022

Feb 02, 2023

BUY
$3.19 - $6.46 $4,456 - $9,024
1,397 Added 5.41%
27,212 $107,000
Q3 2022

Nov 04, 2022

BUY
$5.58 - $9.04 $5,831 - $9,446
1,045 Added 4.22%
25,815 $155,000
Q2 2022

Aug 01, 2022

SELL
$4.12 - $9.35 $45,085 - $102,317
-10,943 Reduced 30.64%
24,770 $160,000
Q1 2022

May 10, 2022

SELL
$5.24 - $15.58 $51,053 - $151,795
-9,743 Reduced 21.43%
35,713 $295,000
Q4 2021

Feb 08, 2022

BUY
$15.18 - $23.15 $522,040 - $796,128
34,390 Added 310.77%
45,456 $704,000
Q3 2021

Nov 12, 2021

BUY
$16.29 - $25.88 $180,265 - $286,388
11,066 New
11,066 $249,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $529M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.